ライフサイエンスコーパス: photopheresis

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 and prednisone) alone or in conjunction with photopheresis.

2 disease patients treated with extracorporeal photopheresis, a form of systemic PUVA.

3 titox, mycophenolate mofetil, extracorporeal photopheresis, and several monoclonal antibodies have be

4 tosis in patients clearing on extracorporeal photopheresis but persisted in nonresponsive patients.

5 The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to 24 weeks together with sta

6 Extracorporeal photopheresis (ECP) is a widely used clinical cell-based

7 Extracorporeal photopheresis (ECP) is an important therapeutic option i

8 Extracorporeal photopheresis (ECP) is considered a valid second-line tr

9 gulatory T (Treg) cells after extracorporeal photopheresis (ECP) is thought to contribute to how ECP

10 Extracorporeal photopheresis (ECP), a technique that exposes isolated w

11 Extracorporeal photopheresis (ECP), an immunomodulating procedure that

12 disease (cGVHD) treated with extracorporeal photopheresis (ECP).

13 Apoptosis can be induced by extracorporeal photopheresis (ECP).

14 py group, as compared with 0.91+/-1.0 in the photopheresis group (P=0.04).

15 Significantly more patients in the photopheresis group had one rejection episode or none (2

16 27), and significantly fewer patients in the photopheresis group had two or more rejection episodes (

17 The photopheresis group received a total of 24 photopheresis

18 etected significantly less frequently in the photopheresis group than in the standard-therapy group (

19 bexarotene, interferon alpha, extracorporeal photopheresis, histone deacetylase inhibitors, and antib

20 y study to assess the safety and efficacy of photopheresis in the prevention of acute rejection of ca

21 Photopheresis is an immunoregulatory technique in which

22 Extracorporeal photopheresis is confirmed as an effective second-line t

23 nti-LFA-3-IgG fusion protein, extracorporeal photopheresis, mesenchymal stem cells and regulatory T c

24 systemic immunosuppressants, extracorporeal photopheresis, or phototherapy.

25 ts for chronic GVHD including extracorporeal photopheresis, rituximab, sirolimus, mycofenolate mofeti

26 loaded dendritic cells as well as the use of photopheresis to generate an anti-idiotype cytotoxic T-c

27 In this pilot study, the addition of photopheresis to triple-drug immunosuppressive therapy s

28 e photopheresis group received a total of 24 photopheresis treatments, each pair of treatments given

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。